Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy-Reference-Cited by-同舟云学术

Alternative Response Criteria and Clinical Risk Factors for Assessing Tumor Response in Patients With Metastatic Renal Cell Carcinoma Who Are Receiving Salvage Therapy

Published:2017-12 Issue:6 Volume:209 Page:1278-1284
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Kang Hyunseon C.¹,Gupta Shiva¹,Wei Wei²,Lu Lina¹,Matrana Marc R.³,Tannir Nizar M.⁴,Choi Haesun¹

Affiliation:

1. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1473, Houston, TX 77030.

2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.

3. Department of Hematology and Oncology, Ochsner Cancer Institute, New Orleans, LA.

4. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Link

http://www.ajronline.org/doi/pdf/10.2214/AJR.17.18018

Reference23 articles.

1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

2. Change in Tumor Size by RECIST Correlates Linearly With Overall Survival in Phase I Oncology Studies

3. Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

4. Primary Tumor Response to Targeted Agents in Patients with Metastatic Renal Cell Carcinoma

5. Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of enhancement modifications in evaluating tumor response to immunotherapy in metastatic renal cell carcinoma;Tumori Journal;2023-07-28

2. A Concise Review of the Multimodality Imaging Features of Renal Cell Carcinoma;Cureus;2021-02-08

3. Criteria for Responses of Renal Cancer Metastases to Targeted and Immunotherapy;Journal of radiology and nuclear medicine;2020-09-05

4. Imaging for Metastatic Renal Cell Carcinoma;Urologic Clinics of North America;2020-08

5. Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC);Abdominal Radiology;2019-12-10